Loading…
PRFX
PRF Technologies Ltd.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP M77798201
$0.96-2.92%Price as of Aug 29, 18:50 UTC · updated once a day, after the close
Key metrics
- Market cap
- $2.92M
- P/E
- —
- Forward P/E
- —
- P/B
- 0.1x
- Dividend yield
- —
- Payout
- —
- EPS
- -$7.24
- ROE
- -90.37%
- Profit margin
- 0.00%
- Revenue growth
- —
- Beta
- 1.04
- 52-week high
- $9.00
- 52-week low
- $0.91
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -99.9% over 5Y.
today you would have $1.18▼ -99.9%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $3.21 | $16.77 | $82.50 | $123.90 | |
| P/S | — | 76.0x | — | — | — |
| P/B | 0.2x | 0.2x | 2.7x | 0.2x | 0.1x |
| EPS | — | -$105.52 | -$122.94 | -$317.30 | |
| Profit margin | — | -29541.18% |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MTNBMatinas BioPharma Holdings, Inc. | $0.20 | — | 0.7x | — | -141.24% | $2.94M |
| MEDSDataMeds AI, Inc. | $0.96 | — | — | — | — | $2.94M |
| BIAFbioAffinity Technologies, Inc. | $4.87 | — | 0.6x | — | -1860.15% | $2.88M |
| GNPXGenprex, Inc. | $3.67 |
About the company
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
- 6
- Tel Aviv-Yafo, Israel
Company description provided by Yahoo Finance.